Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Online Health Seeking Behaviours: What Information Is Sought by Women Experiencing Miscarriage?

Pang PC, Temple-Smith M, Bellhouse C, Trieu VH, Kiropoulos L, Williams H, Coomarasamy A, Brewin J, Bowles A, Bilardi J.

Stud Health Technol Inform. 2018;252:118-125.

PMID:
30040693
2.

Direct electrochemical generation of organic carbonates by dehydrogenative coupling.

Gieshoff T, Trieu V, Heijl J, Waldvogel SR.

Beilstein J Org Chem. 2018 Jun 27;14:1578-1582. doi: 10.3762/bjoc.14.135. eCollection 2018.

3.

Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.

D'Cruz OJ, Qazi S, Hwang L, Ng K, Trieu V.

Onco Targets Ther. 2018 May 14;11:2779-2796. doi: 10.2147/OTT.S161905. eCollection 2018.

4.

Spectroscopic Investigation of the Electrosynthesis of Diphenyl Carbonate from CO and Phenol on Gold Electrodes.

Figueiredo MC, Trieu V, Eiden S, Heijl J, Koper MTM.

ACS Catal. 2018 Apr 6;8(4):3087-3090. doi: 10.1021/acscatal.7b04204. Epub 2018 Mar 6.

5.

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck.

Trieu V, Pinto H, Riess JW, Lira R, Luciano R, Coty J, Boothroyd D, Colevas AD.

Oncologist. 2018 Jul;23(7):764-e86. doi: 10.1634/theoncologist.2017-0618. Epub 2018 Mar 14.

6.

Spectro-Electrochemical Examination of the Formation of Dimethyl Carbonate from CO and Methanol at Different Electrode Materials.

Figueiredo MC, Trieu V, Eiden S, Koper MTM.

J Am Chem Soc. 2017 Oct 18;139(41):14693-14698. doi: 10.1021/jacs.7b08208. Epub 2017 Oct 3.

7.

Minimally Invasive Middle Fossa Keyhole Craniectomy for Repair of Superior Semicircular Canal Dehiscence.

Trieu V, Pelargos PE, Spasic M, Chung LK, Voth B, Ung N, Gopen Q, Yang I.

Oper Neurosurg (Hagerstown). 2017 Jun 1;13(3):317-323. doi: 10.1093/ons/opw046.

PMID:
28521355
8.

Killer cell immunoglobulin receptor profile on CD4(+)  CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.

Zal B, Chitalia N, Ng YS, Trieu V, Javed S, Warrington R, Kaski JC, Banerjee D, Baboonian C.

Immunology. 2015 May;145(1):105-13. doi: 10.1111/imm.12429.

9.

Microstructural impact of anodic coatings on the electrochemical chlorine evolution reaction.

Chen R, Trieu V, Zeradjanin AR, Natter H, Teschner D, Kintrup J, Bulan A, Schuhmann W, Hempelmann R.

Phys Chem Chem Phys. 2012 May 28;14(20):7392-9. doi: 10.1039/c2cp41163f. Epub 2012 Apr 24.

PMID:
22531826
10.

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE, Korn RL, Desai N, Trieu V, Iglesias JL, Zhang H, Soon-Shiong P, Shi T, Rajeshkumar NV, Maitra A, Hidalgo M.

J Clin Oncol. 2011 Dec 1;29(34):4548-54. doi: 10.1200/JCO.2011.36.5742. Epub 2011 Oct 3.

11.

Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.

Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S.

Neoplasia. 2011 Apr;13(4):327-38.

12.

MicroRNA-101-mediated Akt activation and estrogen-independent growth.

Sachdeva M, Wu H, Ru P, Hwang L, Trieu V, Mo YY.

Oncogene. 2011 Feb 17;30(7):822-31. doi: 10.1038/onc.2010.463. Epub 2010 Oct 18.

PMID:
20956939
13.

SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients.

Desai N, Trieu V, Damascelli B, Soon-Shiong P.

Transl Oncol. 2009 May;2(2):59-64.

14.

Aberrant promoter methylation of SPARC in ovarian cancer.

Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC, Motamed K.

Neoplasia. 2009 Feb;11(2):126-35.

15.

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.

Desai NP, Trieu V, Hwang LY, Wu R, Soon-Shiong P, Gradishar WJ.

Anticancer Drugs. 2008 Oct;19(9):899-909. doi: 10.1097/CAD.0b013e32830f9046.

PMID:
18766004
16.
17.

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P.

Clin Cancer Res. 2006 Feb 15;12(4):1317-24. Erratum in: Clin Cancer Res. 2006 Jun 15;12(12):3869. Dosage error in article text.

18.

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

Nyman DW, Campbell KJ, Hersh E, Long K, Richardson K, Trieu V, Desai N, Hawkins MJ, Von Hoff DD.

J Clin Oncol. 2005 Nov 1;23(31):7785-93.

PMID:
16258082
19.

The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis.

Zimmermann G, Favrod J, Trieu VH, Pomini V.

Schizophr Res. 2005 Sep 1;77(1):1-9.

PMID:
16005380
20.

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

Sparreboom A, Scripture CD, Trieu V, Williams PJ, De T, Yang A, Beals B, Figg WD, Hawkins M, Desai N.

Clin Cancer Res. 2005 Jun 1;11(11):4136-43.

21.

EGF-genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model.

Trieu VN, Narla RK, Myers DE, Uckun FM.

J Cardiovasc Pharmacol. 2000 Apr;35(4):595-605.

PMID:
10774791
22.

Apolipoprotein E and apolipoprotein D expression in a murine model of singlet oxygen-induced cerebral stroke.

Trieu VN, Uckun FM.

Biochem Biophys Res Commun. 2000 Feb 24;268(3):835-41.

PMID:
10679292
24.

Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.

Dong Y, Venkatachalam TK, Narla RK, Trieu VN, Sudbeck EA, Uckun FM.

Bioorg Med Chem Lett. 2000 Jan 3;10(1):87-90.

PMID:
10636251
25.

A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Trieu VN, Liu R, Liu XP, Uckun FM.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):22-5.

PMID:
10623568
26.

In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke.

Trieu VN, Dong Y, Zheng Y, Uckun FM.

Radiat Res. 1999 Nov;152(5):508-16.

PMID:
10523874
27.

Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke.

Trieu VN, Uckun FM.

Biochem Biophys Res Commun. 1999 May 19;258(3):685-8.

PMID:
10329446
28.

Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis.

Trieu VN, Uckun FM.

Biochem Biophys Res Commun. 1999 Apr 21;257(3):714-8.

PMID:
10208849
29.
30.

Functional characterization of T7 and T8 of human apolipoprotein (a).

Trieu VN, McConathy WJ.

Biochem Biophys Res Commun. 1998 Oct 9;251(1):356-9.

PMID:
9790960
31.

Male-associated hypertension in LDL-R deficient mice.

Trieu VN, Uckun FM.

Biochem Biophys Res Commun. 1998 Jun 18;247(2):277-9.

PMID:
9642116
32.

The binding of animal low-density lipoproteins to human apolipoprotein(a).

Trieu VN, McConathy WJ.

Biochem J. 1995 Aug 1;309 ( Pt 3):899-904.

33.

A two-step model for lipoprotein(a) formation.

Trieu VN, McConathy WJ.

J Biol Chem. 1995 Jun 30;270(26):15471-4.

34.

Apoc-III-beta-galactosidase hybrid distinguishes between VLDL and LDL phospholipids.

Trieu VN, McConathy WJ.

Biochem Biophys Res Commun. 1995 Jun 26;211(3):754-60.

PMID:
7598703
35.
36.

Triglyceride-rich lipoprotein interactions with Lp(a).

McConathy WJ, Trieu VN, Koren E, Wang CS, Corder CC.

Chem Phys Lipids. 1994 Jan;67-68:105-13.

PMID:
8187204
37.

Sequence of the porcine apoA-I gene.

Trieu VN, Patel B, Zhan R, Black DD.

Gene. 1993 Dec 8;134(2):267-70.

PMID:
7916724
38.

Sequences and expression of the porcine apolipoprotein A-I and C-III mRNAs.

Trieu VN, Hasler-Rapacz J, Rapacz J, Black DD.

Gene. 1993 Jan 30;123(2):173-9.

PMID:
8428656
39.

Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.

Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ.

J Biol Chem. 1991 Mar 25;266(9):5480-5.

40.

Lp(a) interactions.

McConathy WJ, Trieu VN.

Prog Lipid Res. 1991;30(2-3):195-203.

PMID:
1840454
41.

Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins.

Trieu VN, McConathy WJ.

Biochemistry. 1990 Jun 26;29(25):5919-24.

PMID:
2143418
42.

Improved plasmid shuttle vectors for Haemophilus influenzae and Escherichia coli.

Trieu VN, McCarthy D.

Gene. 1990 Jan 31;86(1):99-102.

PMID:
2179060
43.

Lp(a) and plasma triglyceride-rich lipoproteins.

McConathy WJ, Trieu VN, Klör HU, Corder CN.

Klin Wochenschr. 1990;68 Suppl 22:117-9.

PMID:
2150869
44.
45.

Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).

Ye SQ, Trieu VN, Stiers DL, McConathy WJ.

J Biol Chem. 1988 May 5;263(13):6337-43.

Supplemental Content

Support Center